Sandoz/Cinpharm partnership to increase medicine access in Sub-Saharan Africa

摘要

Making high-quality medicines available at an affordable cost is a challenge, but to do so in an emerging area such as sub-Saharan Africa takes considerable effort. In April, Sandoz announced that through its German affiliate, 1A Pharma GmbH (1A Pharrma), the company signed a partnership agreement with Cinpharm S.A. (Cinpharm), a Cameroon-owned and operated generic Pharmaceuticals manufacturing company, for the local production of high-quality medicines for the Sub-Saharan African region.